Filing Details
NextCure, Inc. (NASDAQ:NXTC) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:NXTC
NextCure, Inc. (NXTC) Reports Material Event to SEC
Filing Details NextCure, Inc. (NASDAQ:NXTC) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context NextCure,…
Market Context
NextCure, Inc.'s stock currently trades at $1.65 with a market capitalization of $30.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NextCure, Inc.'s stock.
All SEC filings for NextCure, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NXTC Stock Page
Frequently Asked Questions
Where can I read NXTC's SEC filings?
Browse all filings on our NXTC SEC filings page.
What types of SEC filings does NextCure, Inc. file?
Public companies like NextCure, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.